Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision modelFrederick W. Thielen, Carin A. Uyl‐de Groot, Liesbeth E.M. Oosten et al.|European Journal Of Haematology|2018Cited by 6